Key Takeaways MCK posted Q3 EPS of $9.34, topping estimates, as revenues rose 11.4% to $106.16B.MCK's results were driven by higher prescription volumes and strong growth in oncology and multispecialty.MCK raised fiscal 2026 EPS guidance to $38.80$39.20 and lifted expected revenue growth to 12-16%.McKesson Corporation (MCK) reported third-quarter fiscal 2026 adjusted earnings per share (EPS) of $9.34, which beat the Zacks Consensus Estimate of $9.31 by 0.3%. The bottom line improved 16.3% on a year-over-yea ...

来源：国际投行研究报告 雅诗兰黛下跌19% 增长恐慌拖累美股再次下跌！ 疲软的劳动力市场数据和对AI的忧虑进一步拉低美国股市，标普500指数年内转跌。软件股也再次大幅 下跌；比特币下跌13%，拖累Strategy股价下跌19%。 标普500指数信息技术板块下跌1.7%。微软(Microsoft)下跌5%，Salesforce回落4.7%。这轮跌势继续冲击 半导体公司，包括Advanced Micro Devices，该公司收盘下跌3.9%；以及英伟达(Nvidia)，该公司收盘下 跌1.4%。 Alphabet股价下跌0.5%，此前这家谷歌(Google)的母公司表示，今年可能进行最高可达1,850亿美元的人 工智能相关资本投资。高通(Qualcomm)发布的疲软预测拖累了这家芯片制造商的股价，其股价下跌了 8.5%。 雅诗兰黛(Estée Lauder)股价下跌19%，在标普500指数成份股中跌幅最大，此前这家美妆集团表示，预 计今年与关税相关的不利因素将使其利润减少约1亿美元。发动机制造商康明斯(Cummins)股价下跌 11%，创下自2020年3月新冠疫情爆发之初以来的最大单日百分比跌幅。 投资者涌入公 ...

U.S. equities experienced a challenging day on Thursday, February 5, 2026, as a significant sell-off in technology stocks and discouraging reports from the job market weighed heavily on investor sentiment. The tech-heavy Nasdaq Composite (NDAQ) and the benchmark S&P 500 (SPX) both closed sharply lower, marking their third consecutive day of losses, while the Dow Jones Industrial Average (DJIA) also retreated amidst a broad "risk-off" environment.The S&P 500 fell 1.2% to close at 6,798.40, recording its sixt ...

Shares of McKesson Corporation (MCK) are climbing about 16 percent on Thursday morning trading despite no corporate-related announcements to impact the movement.The company's shares are currently trading at $956.61 on the New York Stock Exchange, up 16.27 percent or $133.76. The stock opened at $867.97 and has climbed as high as $964.94 so far in today's session. Over the past year, it has traded in a range of $570.51 to $964.94.The stock movement might be an extended impact of yesterday's third-quarter fi ...

McKesson reported consolidated revenue of $106.2 billion , up 11% year over year. Vitalone attributed the growth to broad-based performance, including higher prescription volumes from retail national account customers in North American Pharmaceutical, continued momentum in Oncology and Multispecialty, expanded distribution of Oncology and Multispecialty products, and meaningful contributions from recent acquisitions.CFO Britt Vitalone said the company delivered record quarterly revenue and adjusted operatin ...

For the quarter ended December 2025, McKesson (MCK) reported revenue of $106.16 billion, up 11.4% over the same period last year. EPS came in at $9.34, compared to $8.03 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $105.66 billion, representing a surprise of +0.47%. The company delivered an EPS surprise of +0.35%, with the consensus EPS estimate being $9.31.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...

McKesson Corporation raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology and specialty drug distribution businesses. ...

McKesson (MCK) came out with quarterly earnings of $9.34 per share, beating the Zacks Consensus Estimate of $9.31 per share. This compares to earnings of $8.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +0.35%. A quarter ago, it was expected that this prescription drug distributor would post earnings of $8.92 per share when it actually produced earnings of $9.86, delivering a surprise of +10.54%.Over the last four quarter ...

McKesson (NYSE:MCK) Q3 2026 Earnings call February 04, 2026 04:30 PM ET Company ParticipantsBrian Tyler - CEOBritt Vitalone - CFOCharles Rhyee - Managing DirectorElizabeth Anderson - Senior Managing DirectorGlen Santangelo - Managing DirectorJeni Dominguez - VP of Investor RelationsKevin Caliendo - Managing DirectorLisa Gill - Managing DirectorMichael Cherny - Senior Managing DirectorConference Call ParticipantsAllen Lutz - Senior Equity Research AnalystBrian Tanquilut - Senior Equity Research AnalystDaniel ...

McKesson (NYSE:MCK) Q3 2026 Earnings call February 04, 2026 04:30 PM ET Company ParticipantsBrian Tyler - CEOBritt Vitalone - CFOCharles Rhyee - Managing DirectorElizabeth Anderson - Senior Managing DirectorGlen Santangelo - Managing DirectorJeni Dominguez - VP of Investor RelationsKevin Caliendo - Managing DirectorLisa Gill - Managing DirectorMichael Cherny - Senior Managing DirectorConference Call ParticipantsAllen Lutz - Senior Equity Research AnalystBrian Tanquilut - Senior Equity Research AnalystDaniel ...